330
Views
3
CrossRef citations to date
0
Altmetric
Case Report

A Randomized Trial of Rapamycin to Increase Longevity and Healthspan in Companion Animals: Navigating the Boundary Between Protections for Animal Research and Human Subjects Research

, , &

References

  • An, J. Y., E. K. Quarles, S. Mekvanich, et al. 2017. Rapamycin treatment attenuates age-associated periodontitis in mice. GeroScience 39(4): 457–463.
  • Johnson, S. C., M. Sangesland, M. Kaeberlein, and P. S. Rabinovitch. 2015. Modulating mTOR in aging and health. Interdisciplinary Topics in Gerontology 40: 107–127. Karger Publishers.
  • Larson, J. C., S. D. Allstadt, T. M. Fan, et al. 2016. Pharmacokinetics of orally administered Low-Dose rapamycin in healthy dogs. American Journal of Veterinary Research 77(1): 65–71.
  • Li, J., S. G. Kim, and J. Blenis. 2014. Rapamycin: One drug, many effects. Cell Metabolism 19(3): 373–9.
  • Urfer, S. R., T. L. Kaeberlein, S. Mailheau, et al. 2017. A randomized controlled trial to establish effects of short-term rapamycin treatment in 24 Middle-aged companion dogs. Geroscience 39(1): 43–127.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.